Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin effects on social attention in adults with autism spectrum disorder and neurotypical controls
2010-022511-18Phase 2Completed
- Sponsor
- University of Freiburg
- Start
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Oxytocin with Placebo (2 arms). Primary endpoints: Reaction time in facial dot-probe paradigm and Saccadic patterns in facial dot-probe paradigm. Started Dec 2010; status: completed.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on 2010-022511-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022511-18.